Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preserving the self: the process of decision making about hereditary breast cancer and ovarian cancer risk reduction.

Qualitative health research - 1 Apr 2011

Howard A Fuchsia, Balneaves Lynda G, Bottorff Joan L, Rodney Patricia

Abstract excerpt

Women who carry BRCA1 or BRCA2 (BRCA1/2) gene mutations have up to an 88% lifetime risk of breast cancer and up to a 65% lifetime risk of ovarian cancer. Strategies to address these risks include cancer screening and risk-reducing surgery (i.e., mastectomy and salpingo-oophorectomy). We conducted a grounded theory study with 22 BRCA1/2 mutation-carrier women to understand how women make decisions about these...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Decision Making
Share to Interview, Psychological

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mastectomy

Share to Neoplastic Syndromes, Hereditary

Share to Ovariectomy

Share to Qualitative Research

Share to Risk Reduction Behavior

Share to Women's Health

Source

Open in PubMed Open full text

Identifiers

PMID: 20980697
DOI: 10.1177/1049732310387798
PMCID: PMC4880460

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preserving the self: the process of decision making about hereditary breast cancer and ovarian cancer risk reduction.PMID 20980697Read ↗

Involvement and Influence of Healthcare Providers, Family Members, and Other Mutation Carriers in the Cancer Risk Management Decision-Making Process of BRCA1 and BRCA2 Mutation Carriers.Semantic proximity Read ↗

Seeking balance: decision support needs of women without cancer and a deleterious BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Cancer risk management decision making for BRCA+ women.Semantic proximity Read ↗

Decision-making for bilateral risk-reducing mastectomy for an increased lifetime breast cancer risk: A qualitative metasynthesis.Semantic proximity Read ↗

Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.Semantic proximity Read ↗

Decision-making process of women carrying a BRCA1 or BRCA2 mutation who have chosen prophylactic mastectomy.Semantic proximity Read ↗

Catalysts towards cancer risk management action: A longitudinal study of reproductive-aged women with BRCA1/2 mutations.Semantic proximity Read ↗

How the "control-fate continuum" helps explain the genetic testing decision-making process: a grounded theory study.Semantic proximity Read ↗

Understanding risk perception and risk-reducing decision-making for surgery among individuals with a genetic predisposition to epithelial ovarian cancer.Semantic proximity Read ↗

Exploring the role of a multidisciplinary hereditary gynecologic oncology clinic in epithelial ovarian cancer risk-reducing surgical decision-making practices: A mixed-methods study.Semantic proximity Read ↗

Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer.Semantic proximity Read ↗

Decision making after BRCA genetic testing. Down the road of transition.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.